06:00 PM EDT, 03/27/2024 (MT Newswires) -- Novo Nordisk ( NVO ) is facing calls by Sen. Bernie Sanders, chairman of the Health, Education, Labor and Pensions Committee, to lower the list price of its diabetes and weight-loss medication Ozempic.

In a Wednesday statement, Sanders cited a recent study at Yale University that found that the drug costs less than $5 a month to manufacture. Sanders also said US patients are charged almost $1,000 per month for the drug, compared to $155 per month in Canada and $59 for patients in Germany.

Novo Nordisk ( NVO ) did not immediately respond to a request for comment by MT Newswires.

Price: 127.95, Change: -0.1, Percent Change: -0.08